|
Important Russell Reset 2021 Data Lineage Cell Therapeutics (LCTX) Joins Russell 3000® And Russell Microcap® Indexes Cocrystal Pharma (COCP) Joins Russell Microcap® Index |
|
Kratos Successfully Completes Engine Testing for an Affordable and High Performance Turbine EngineKratos Defense & Security Solutions announced that Kratos Turbine Technologies Division has successfully completed a core engine test campaign under KTT’s Advanced Turbine Technologies for Affordable Mission (ATTAM) contract |
|
Onconova Therapeutics Provides An Update On The Phase 1/2a Trial Of Rigosertib-Nivolumab Combination In KRAS+ Non-Small Cell Lung CancerOnconova Therapeutics announced an update on the investigator-initiated Phase 1/2a trial of oral rigosertib plus nivolumab in advanced metastatic KRAS mutated (KRAS+) non-small cell lung cancer (NSCLC) Research, News & Market Data on Onconova |
Stay up to date. Follow us: